CC
REGN icon

Corsicana & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Corsicana & Co’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49K Hold
4
– – ﹤0.01% 287
2026
Q1 		$2.54K Hold
4
– – ﹤0.01% 244
2025
Q4 		$3.09K Hold
4
– – ﹤0.01% 231
2025
Q3 		$2.25K Buy
+4
New +$2.26K ﹤0.01% 245

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Corsicana & Co's REGN Position: Q2 2026 in Review

Corsicana & Co held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 4 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Corsicana & Co first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.09K in Q4 2025. 582 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Corsicana & Co held 4 shares of Regeneron Pharmaceuticals worth $2.49K as of Q2 2026.
  • Corsicana & Co left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Corsicana & Co's portfolio in Q2 2026, its #287 holding.
  • Corsicana & Co first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Corsicana & Co's Regeneron Pharmaceuticals position peaked at $3.09K in Q4 2025.
  • 582 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Corsicana & Co's 13F filing for Q2 2026, filed 24 Jul 2026.